FindTrial
Sign In

The role of perirenal fat thickness in the progression of diabetes mellitus

The role of perirenal fat thickness in the progression of diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052518
Enrollment
Unknown
Registered
2021-10-30
Start date
2021-12-20
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Diabetic group:Nil
Early diabetic nephropathy group:Nil
Diabetic nephropathy group:Nil

Sponsors

Renmin's Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with diabetic nephropathy diagnosed by renal biopsy, UACR who met the diagnostic criteria of early diabetic nephropathy, and patients with type 2 diabetes previously diagnosed.

Exclusion criteria

Exclusion criteria: 1. Inpatients in the department of Nephrology with other renal diseases; 2. Patients with tumors and malignant wasting diseases; 3. Patients with primary obesity; 4. Patients who are taking lipid-lowering drugs; 5. Patients diagnosed with type 1 diabetes or other types of diabetes; 6. Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
perirenal fat thickness;—

Countries

China

Contacts

Public ContactHu Hongtu

Renmin's Hospital of Wuhan University

1006124221@qq.com+86 18671148103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026